If you think you are experiencing a medical emergency, please call your doctor immediately or call 911 (if within the United States)
The amount of weight you can lose with GLP-1 agonists varies based on factors like your baseline weight, diet, exercise habits and how your body reacts to the medication
Common side effects reported in clinical trials include: Gastrointestinal disturbances : cramping, diarrhoea, flatulence, constipation, and abdominal discomfort are the most frequently reported adverse effects, occurring in up to 30% of users in some studies Nausea : particularly when starting treatment or taking higher doses These effects are typically mild to moderate and often improve with continued use or dose reduction Less common but important considerations : Berberine may cause a temporary increase in bilirubin levels, which could be problematic in individuals with liver disease Berberine should not be used during pregnancy or breastfeeding due to potential risks to the foetus or infant (including theoretical risk of kernicterus in infants) Berberine is not recommended for use in children or adolescents Allergic reactions, whilst rare, can occur Significant drug interactions are a major concern: Diabetes medications : Berberine may have additive glucose-lowering effects, particularly with insulin and sulphonylureas, increasing the risk of hypoglycaemia
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study
"Effects of folate and vitamin B12 on cognitive function in adults and the elderly"
